News

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...
The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
The Food and Drug Administration approved the first injectable HIV prevention medication, which could be a massive step forward in ending the long-term epidemic.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...